414 related articles for article (PubMed ID: 18808333)
21. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
Deng YH; Sun Z; Yang XL; Bao L
Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
[TBL] [Abstract][Full Text] [Related]
22. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
[TBL] [Abstract][Full Text] [Related]
23. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and protective efficacy of heterologous prime-boost regimens with mycobacterial vaccines and recombinant adenovirus- and poxvirus-vectored vaccines against murine tuberculosis.
You Q; Wu Y; Wu Y; Wei W; Wang C; Jiang D; Yu X; Zhang X; Wang Y; Tang Z; Jiang C; Kong W
Int J Infect Dis; 2012 Nov; 16(11):e816-25. PubMed ID: 22921259
[TBL] [Abstract][Full Text] [Related]
25. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-alpha induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice.
Shen H; Wang C; Yang E; Xu Y; Liu W; Yan J; Wang F; Wang H
Microbiol Immunol; 2010 Aug; 54(8):435-41. PubMed ID: 20646207
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B.
Wang C; Fu R; Chen Z; Tan K; Chen L; Teng X; Lu J; Shi C; Fan X
Clin Dev Immunol; 2012; 2012():563838. PubMed ID: 22570667
[TBL] [Abstract][Full Text] [Related]
27. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
[TBL] [Abstract][Full Text] [Related]
28. rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector.
Magalhaes I; Sizemore DR; Ahmed RK; Mueller S; Wehlin L; Scanga C; Weichold F; Schirru G; Pau MG; Goudsmit J; Kühlmann-Berenzon S; Spångberg M; Andersson J; Gaines H; Thorstensson R; Skeiky YA; Sadoff J; Maeurer M
PLoS One; 2008; 3(11):e3790. PubMed ID: 19023426
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
30. Immune responses induced by heterologous boosting of recombinant bacillus Calmette-Guerin with Ag85B-ESAT6 fusion protein in levamisole-based adjuvant.
You Q; Wu Y; Jiang D; Wu Y; Wang C; Wei W; Yu X; Zhang X; Kong W; Jiang C
Immunol Invest; 2012; 41(4):412-28. PubMed ID: 22360290
[TBL] [Abstract][Full Text] [Related]
31. Targeted induction of antigen expression within dendritic cells modulates antigen-specific immunity afforded by recombinant BCG.
Kong CU; Ng LG; Nambiar JK; Spratt JM; Weninger W; Triccas JA
Vaccine; 2011 Feb; 29(7):1374-81. PubMed ID: 21211591
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of recombinant Mycobacterium bovis bacille Calmette-Guèrin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens.
Mohamud R; Azlan M; Yero D; Alvarez N; Sarmiento ME; Acosta A; Norazmi MN
BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S5. PubMed ID: 23458635
[TBL] [Abstract][Full Text] [Related]
33. Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis.
Counoupas C; Pinto R; Nagalingam G; Britton WJ; Triccas JA
Vaccine; 2018 May; 36(19):2619-2629. PubMed ID: 29627232
[TBL] [Abstract][Full Text] [Related]
34. Dose of incorporated immunodominant antigen in recombinant BCG impacts modestly on Th1 immune response and protective efficiency against Mycobacterium tuberculosis in mice.
Ma H; Wu K; Liu F; Yang H; Kang H; Chen NN; Yuan Q; Zhou WJ; Fan XY
J Immunol Res; 2014; 2014():196124. PubMed ID: 25152895
[TBL] [Abstract][Full Text] [Related]
35. Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen.
Bruffaerts N; Pedersen LE; Vandermeulen G; Préat V; Stockhofe-Zurwieden N; Huygen K; Romano M
PLoS One; 2015; 10(7):e0132288. PubMed ID: 26172261
[TBL] [Abstract][Full Text] [Related]
36. Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice.
Yang E; Gu J; Wang F; Wang H; Shen H; Chen ZW
Microb Pathog; 2016 Apr; 93():1-7. PubMed ID: 26792673
[TBL] [Abstract][Full Text] [Related]
37. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis.
Al-Attiyah R; Mustafa AS; Abal AT; El-Shamy AS; Dalemans W; Skeiky YA
Clin Exp Immunol; 2004 Oct; 138(1):139-44. PubMed ID: 15373916
[TBL] [Abstract][Full Text] [Related]
38. [Study on immunogenicity elicited by a recombinant vaccine of rBCG-Rv3133c to fight against dormancy Mycobacterium tuberculosis].
Deng Y; He H; Zhang B
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):817-21. PubMed ID: 24059063
[TBL] [Abstract][Full Text] [Related]
39. Recombinant
Liu W; Xu Y; Shen H; Yan J; Yang E; Wang H
Exp Ther Med; 2017 May; 13(5):2339-2347. PubMed ID: 28565847
[TBL] [Abstract][Full Text] [Related]
40. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
